Marketscreener, stock market website
b3745073b041ce15.zylo3H4vs-csLDwEGLLNrZuaPr-rUDfvWN-9-tPjzZU.h1AsqFNa8rFhamRsVsiewvn4adzuPUGbMJH_w-qLmK2NegG2U3Drrh9WCA

Log In

Forgot your password ?
Or log in with
GoogleGoogle

Email Registration
Or log in with
GoogleGoogle
Log In

Forgot your password ?
Not a member ?
Email Registration
Or log in with
GoogleGoogle
  • Markets
    Equities
    Top Capitalization
    United Kingdom
    North America
    Europe
    Asia
    Middle East
    Sector Research
    Company calendar
    Equities Analysis
    Most popular
    NVIDIA CORPORATION
    TESLA, INC.
    BP PLC
    AIRBUS SE
    RHEINMETALL AG
    META PLATFORMS, INC.
    ROLLS-ROYCE HOLDINGS PLC
    Indices
    Homepage
    Rankings
    Europe
    America
    Asia
    Africa
    Index Analysis
    Indexes News
    FTSE 100
    DAX
    CAC 40
    EURO STOXX 50
    S&P 500
    NASDAQ 100
    TSX COMP
    SHANGHAI COMPOSITE
    Currency / Forex
    Homepage
    Rankings
    Currency Cross Rate
    Currency Converter
    Forex Analysis
    Currencies News
    GBP / USD
    GBP / EUR
    GBP / CHF
    GBP / RUB
    GBP / SEK
    Commodities
    Homepage
    Energy
    Precious metals
    Agriculture
    Industrial Metals
    Livestock and Cattle
    GOLD
    CRUDE OIL (WTI)
    CRUDE OIL (BRENT)
    SILVER
    PLATINUM
    Cryptocurrencies
    Homepage
    Rankings
    Charts
    Analysis
    News
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    Interest Rates
    Homepage
    Yield Curve
    Developed Nations
    Emerging Countries
    ETF
    Summary
    Screener
    Analysis
    News
  • News
    All News
    World
    United Kingdom
    Europe
    North America
    South America
    Asia
    Africa
    Middle East
    Emerging
    Companies
    All News
    Analyst Reco.
    Rumors
    IPOs
    Capital Markets Transactions
    New Contracts
    Profit Warnings
    Appointments
    Press Releases
    Security Transactions
    Earnings reports
    New markets
    New products
    Corporate strategies
    Legal risks
    Share buybacks
    Mergers and acquisitions
    Call Transcripts
    Guidance
    Indices
    Currency / Forex
    Commodities
    Cryptocurrencies
    ETF
    Interest Rates
    Economy
    Themes
    Asset Management
    Activism
    Climate and ESG
    Cybersecurity
    Geopolitics
    Central Banks
    Inflation
    Business Leaders
    Sectors
    Calendar
    Economic Calendar
    Company calendar
    All our articles
    Most Read News
    Hot News
  • Analysis
    All Analysis
    Must Read
    Equities
    Interviews
    Indices
    Currencies
    Commodities
    ETF
    Cryptocurrencies
    Stock Trading Strategies
    All
    America
    Europe
    Asia
  • Our Shows
    Shows
    Must Watch
    Satirical Cartoon
    Today's Editorial
    Crypto Recap
  • Stock Picks
    All our investments
    United States
    Europe
    Asia, Pacific
  • Portfolios
    Virtual Portfolios
    European Portfolio
    USA Portfolio
    Asian Portfolio
  • Watchlists
    My Watchlists
    Watchlists
    My previous session
    My most visited
    Most popular
    Investment Style
    Homepage
    Trend-Following Stocks
    Growth stocks at reasonable prices
    Quality stocks
    Multibaggers
    Dividend Aristocrats
    Growth stocks
    Investment Themes
    Homepage
    Smart home
    Strategic Metals
    REITS
    Adtechs
    Smart City
    The food of tomorrow
  • Rankings
    Top Movers
    Short-Term Gainers & Losers
    Long-term Gainers & Losers
    Unusual volumes
    New Historical Highs
    New Historical Lows
    Top Fundamentals
    Fundamental Composite
    Sales growth
    Earnings Growth
    Profitability
    Finances
    Rankings Valuation
    Valuation Composite
    Capitalization
    P/E ratio
    Enterprise value
    Yield
    Price to Book (PBR)
    Free Cash Flow (FCF)
    Top Consensus
    Consensus composite
    Analyst Opinion
    Target price
    Opinion Divergences
    Estimates Revisions
    Analyst coverage
    Technical Analysis Rankings
    RSI
    GAPS
    STIM
    Daily Breakouts
    Weekly Breakouts
    Trends
    Volatility
    Top ranking ESG
    ESG MSCI
    Environment
    Social
    Governance
    Islamic Finance
    Paris Agreement
  • Screeners
    Stock Screener Home
    Investment Themes
    Israeli innovation
    The genomic revolution
    Robotics
    Millennials
    Bionic engineering
    Boats
    Technical Rankings
    Oversold stocks
    Overbought stocks
    Close to resistance
    Close to support
    Accumulation Phases
    Most volatile stocks
    Fundamental Rankings
    Top Investor Rating
    Top Trading Rating
    Top Consensus
    Top Growth
    Top Dividends
    Low valuations
    My Screeners
    All my stocks
    Watchlists
    Virtual Portfolios
  • Tools
    MarketScreener tools
    Stock Screener
    iPhone app
    Expert tools
    Stock Screener PRO
    Portfolio Creator
    Event Screener
    Dynamic Chart
    Company calendar
    Economic Calendar
    Currency Converter
  • Our Services
    Our subscriptions
    Our Stock Picks
    Stock Screener
    Thematic Investment Lists
    MarketScreener Portfolios
    European Portfolio
    USA Portfolio
    Asian Portfolio
  • Homepage
  • Markets
    • Equities
      • Top Capitalization
      • United Kingdom
      • North America
      • Europe
      • Asia
      • Middle East
      • Sector Research
      • Company calendar
      • Equities Analysis
      • Most popular
      • NVIDIA CORPORATION
      • TESLA, INC.
      • BP PLC
      • AIRBUS SE
      • RHEINMETALL AG
      • META PLATFORMS, INC.
      • ROLLS-ROYCE HOLDINGS PLC
    • Indices
      • Homepage
      • Rankings
      • Europe
      • America
      • Asia
      • Africa
      • Index Analysis
      • Indexes News
      • FTSE 100
      • DAX
      • CAC 40
      • EURO STOXX 50
      • S&P 500
      • NASDAQ 100
      • TSX COMP
      • SHANGHAI COMPOSITE
    • Currency / Forex
      • Homepage
      • Rankings
      • Currency Cross Rate
      • Currency Converter
      • Forex Analysis
      • Currencies News
      • GBP / USD
      • GBP / EUR
      • GBP / CHF
      • GBP / RUB
      • GBP / SEK
    • Commodities
      • Homepage
      • Energy
      • Precious metals
      • Agriculture
      • Industrial Metals
      • Livestock and Cattle
      • GOLD
      • CRUDE OIL (WTI)
      • CRUDE OIL (BRENT)
      • SILVER
      • PLATINUM
    • Cryptocurrencies
      • Homepage
      • Rankings
      • Charts
      • Analysis
      • News
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    • Interest Rates
      • Homepage
      • Yield Curve
      • Developed Nations
      • Emerging Countries
    • ETF
      • Summary
      • Screener
      • Analysis
      • News
  • News
    • All News
      • World
      • United Kingdom
      • Europe
      • North America
      • South America
      • Asia
      • Africa
      • Middle East
      • Emerging
    • Companies
      • All News
      • Analyst Reco.
      • Rumors
      • IPOs
      • Capital Markets Transactions
      • New Contracts
      • Profit Warnings
      • Appointments
      • Press Releases
      • Security Transactions
      • Earnings reports
      • New markets
      • New products
      • Corporate strategies
      • Legal risks
      • Share buybacks
      • Mergers and acquisitions
      • Call Transcripts
      • Guidance
    • Indices
    • Currency / Forex
    • Commodities
    • Cryptocurrencies
    • ETF
    • Interest Rates
    • Economy
    • Themes
      • Asset Management
      • Activism
      • Climate and ESG
      • Cybersecurity
      • Geopolitics
      • Central Banks
      • Inflation
      • Business Leaders
    • Sectors
    • Calendar
      • Economic Calendar
      • Company calendar
    • All our articles
    • Most Read News
    • Hot News
  • Analysis
    • All Analysis
    • Must Read
    • Equities
    • Interviews
    • Indices
    • Currencies
    • Commodities
    • ETF
    • Cryptocurrencies
    • Stock Trading Strategies
      • All
      • America
      • Europe
      • Asia
  • Our Shows
    • Shows
    • Must Watch
    • Satirical Cartoon
    • Today's Editorial
    • Crypto Recap
  • Stock Picks
    • All our investments
    • United States
    • Europe
    • Asia, Pacific
  • Portfolios
    • Virtual Portfolios
    • European Portfolio
    • USA Portfolio
    • Asian Portfolio
  • Watchlists
    • My Watchlists
      • Watchlists
      • My previous session
      • My most visited
      • Most popular
    • Investment Style
      • Homepage
      • Trend-Following Stocks
      • Growth stocks at reasonable prices
      • Quality stocks
      • Multibaggers
      • Dividend Aristocrats
      • Growth stocks
    • Investment Themes
      • Homepage
      • Smart home
      • Strategic Metals
      • REITS
      • Adtechs
      • Smart City
      • The food of tomorrow
  • Rankings
    • Top Movers
      • Short-Term Gainers & Losers
      • Long-term Gainers & Losers
      • Unusual volumes
      • New Historical Highs
      • New Historical Lows
    • Top Fundamentals
      • Fundamental Composite
      • Sales growth
      • Earnings Growth
      • Profitability
      • Finances
    • Rankings Valuation
      • Valuation Composite
      • Capitalization
      • P/E ratio
      • Enterprise value
      • Yield
      • Price to Book (PBR)
      • Free Cash Flow (FCF)
    • Top Consensus
      • Consensus composite
      • Analyst Opinion
      • Target price
      • Opinion Divergences
      • Estimates Revisions
      • Analyst coverage
    • Technical Analysis Rankings
      • RSI
      • GAPS
      • STIM
      • Daily Breakouts
      • Weekly Breakouts
      • Trends
      • Volatility
    • Top ranking ESG
      • ESG MSCI
      • Environment
      • Social
      • Governance
      • Islamic Finance
      • Paris Agreement
  • Screeners
    • Stock Screener Home
    • Investment Themes
      • Israeli innovation
      • The genomic revolution
      • Robotics
      • Millennials
      • Bionic engineering
      • Boats
    • Technical Rankings
      • Oversold stocks
      • Overbought stocks
      • Close to resistance
      • Close to support
      • Accumulation Phases
      • Most volatile stocks
    • Fundamental Rankings
      • Top Investor Rating
      • Top Trading Rating
      • Top Consensus
      • Top Growth
      • Top Dividends
      • Low valuations
    • My Screeners
      • All my stocks
      • Watchlists
      • Virtual Portfolios
  • Tools
    • MarketScreener tools
      • Stock Screener
      • iPhone app
    • Expert tools
      • Stock Screener PRO
      • Portfolio Creator
      • Event Screener
    • Dynamic Chart
    • Company calendar
    • Economic Calendar
    • Currency Converter
  • Our Services
    • Our subscriptions
    • Our Stock Picks
    • Stock Screener
    • Thematic Investment Lists
    • MarketScreener Portfolios
      • European Portfolio
      • USA Portfolio
      • Asian Portfolio
Stock MIRMMIRUM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Mirum Pharmaceuticals, Inc.

Equities

MIRM

US6047491013

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
21:00:00 12/06/2025 BST
5-day change 1st Jan Change
49.02 USD +1.16% Intraday chart for Mirum Pharmaceuticals, Inc. +9.89% +18.55%
06-04 Mirum Pharmaceuticals Insider Sold Shares Worth $377,843, According to a Recent SEC Filing MT
05-19 Mirum Pharmaceuticals, Inc. Appoints Doug Sheehy, JD, as Chief Legal Officer CI
Summary
Quotes
Charts
Technical Analysis Static Chart News Chart Sector Chart Comparison Chart Relative Strength Chart
News
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
Company
Profile Governance Share ownership Connections
Financials
Analysts' Forecasts Income Statement Balance Sheet Cash flow Financial Ratios Business Segments
Valuation
Valuation ratios Dividend
Consensus
Analysts' Opinion Estimates Revisions
Ratings
Calendar
Sector
Sector performance Sector valuations Sector dividends Financial comparisons Sector ratings Sector consensus Sector revisions
ETFs
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Sector Update: Health Care Stocks Ease in Afternoon Trading

Published on 17/06/2024 at 19:00, updated on 17/06/2024 at 19:01

Share
LockThis article is reserved for members
Unlock the article: REGISTER NOW!
100% Free Registration
Already a customer? Log In
Share
mtnewswires logo
© MT Newswires - 2024

Latest news about Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals Insider Sold Shares Worth $377,843, According to a Recent SEC Filing 06-04 MT
Mirum Pharmaceuticals, Inc. Appoints Doug Sheehy, JD, as Chief Legal Officer 05-19 CI
Mirum Pharmaceuticals, Inc. Presents New Data from its Phase 2b VANTAGE Study at European Association for Study of Liver Meeting in Amsterdam, Netherlands 05-09 CI
Earnings Flash (MIRM) Mirum Pharmaceuticals Reports Q1 Revenue $111.6M, vs. FactSet Est of $98.4M 05-07 MT
Earnings Flash (MIRM) Mirum Pharmaceuticals Reports Q1 Loss $0.30 Per Share, vs. FactSet Est of $-0.31 05-07 MT
Mirum Pharmaceuticals, Inc., Q1 2025 Earnings Call, May 07, 2025 05-07
Mirum Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 05-07 CI
Mirum Pharmaceuticals, Inc. Raises Revenue Guidance for the Year 2025 05-07 CI
Mirum Pharmaceuticals Announces to Present 28-Week Data from Phase 2B VANTAGE PBC Study At Upcoming Medical Congress 04-28 CI
Mirum Pharmaceuticals Says FDA Approves Tablet Formulation of Treatment for Cholestatic Pruritus 04-14 MT
Mirum'S Livmarli Now FDA Approved In Tablet Formulation 04-14 RE
Mirum Pharmaceuticals Says Livmarli Approved in Japan for Pruritus 03-27 MT
LIVMARLI Now Approved In Japan For ALGS And PFIC 03-27 RE
Mirum Pharmaceuticals Insider Sold Shares Worth $676,928, According to a Recent SEC Filing 03-05 MT
Mirum Pharmaceuticals, Inc., Q4 2024 Earnings Call, Feb 26, 2025 02-26
Mirum Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 02-26 CI
Earnings Flash (MIRM) Mirum Pharmaceuticals Reports Q4 Revenue $99.4M, vs. FactSet Est of $96.6M 02-26 MT
BioMarin Pharmaceutical Inc. Announces Appointment of Timothy P. Walbert to Board of Directors 02-24 CI
Mirum Pharmaceuticals Says US FDA Approves Cerebrotendinous Xanthomatosis' Treatment Drug 02-24 MT
Correction to FDA Approves Mirum Pharmaceuticals Treatment Article 02-21 DJ
Mirum Pharmaceuticals' Lipid Storage Disease Treatment Gets FDA Approval 02-21 MT
FDA Approves Mirum Pharmaceuticals Treatment for Lipid-Storage Disease 02-21 DJ
Mirum Pharmaceuticals Inc. Announces FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease 02-21 CI
US FDA approves Mirum Pharma's genetic disorder drug 02-21 RE
FDA Approves First Treatment For Cerebrotendinous Xanthomatosis, A Rare Lipid Storage Disease 02-21 RE

Chart Mirum Pharmaceuticals, Inc.

Chart Mirum Pharmaceuticals, Inc.
MIRM: Dynamic Chart

Company Profile

Logo Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the identification, acquisition, development and commercialization of therapies for debilitating rare and orphan diseases. It has three medicines: LIVMARLI (maralixibat) oral solution (Livmarli), Cholbam (cholic acid) capsules, and Chenodal (chenodiol) tablets. Livmarli is an orally administered, minimally-absorbed ileal bile acid transporter (IBAT) inhibitor (IBATi) that is used for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) in the United States and various other countries and for cholestatic pruritus in patient with progressive familial intrahepatic cholestasis (PFIC) in the United States. Cholbam is used for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders. It is also advancing its product candidate, volixibat, for the treatment of adult patients with cholestatic liver diseases.
Employees
334
Sector
Pharmaceuticals
Calendar
07-30 - Q2 2025 Earnings Release (Projected)
More about the company

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
48.46USD
Average target price
68.60USD
Spread / Average Target
+41.56%
Consensus
EPS Estimates
Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar
Indices Europe America Asia
More Indexes
My Watchlist
 

My lists
Rankings
 

More Top / Flop
Rankings
 

More Top / Flop

Currency / Forex

Forex

Commodities

Commodities

Cryptocurrencies

Cryptocurrencies
  1. Stock Market
  2. Equities
  3. MIRM Stock
  4. News Mirum Pharmaceuticals, Inc.
  5. Sector Update: Health Care Stocks Ease in Afternoon Trading
Best financial portal

Best financial
portal

+951% of historicalperformance

+951% of historical
performance

More than 20 yearsat your side

More than 20 years
at your side

Trustpilot
+ 1,000,000members

+ 1,000,000
members

Quick & easycancellation

Quick & easy
cancellation

Our Expertsare here for you

Our Experts
are here for you

Download from Apple Store

OUR EXPERTS ARE HERE FOR YOU

Monday - Friday 9am-12pm / 2pm-6pm GMT + 1

Contact us
MarketScreener, Stock Market Live
Legal information | Cookie settings | About us | Copyright © 2025 Surperformance SAS. All rights reserved.
Stock quotes are provided by Factset, Morningstar and S&P Capital IQ
All transcripts on over 9000 companies, on the day they post their earnings!
Unlock them now!
Unlock them now!

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States
United-States
Canada
Canada

MIDDLE EAST

Saudi Arabia
Saudi Arabia
United Arab Emirates
United Arab Emirates

EUROPE

France
France
Deutschland
Deutschland
Suisse
Suisse
Schweiz
Schweiz
Italia
Italia
Österreich
Österreich
België
België
Nederland
Nederland
España
España
Sverige
Sverige
United Kingdom
United Kingdom

APAC

Australia
Australia
India
India
Hong Kong
Hong Kong